FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to oncology, and can be used for prediction of recurrent thyroid cancer after radical surgical intervention. 6 months after the operation, blood is sampled from an ulnar vein. Total microRNA is recovered from blood serum. Expression of siRNA-146b is determined. If the level of siRNA-146b expression in blood serum exceeds 1.08, the development of a recurrence of the disease is predicted in the next two years after the radical surgical intervention.
EFFECT: method enables predicting the development of recurrent thyroid cancer in the next two years after the radical surgical intervention by determining the level of siRNA-146b expression in blood serum.
1 cl, 3 dwg, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RISK OF RECURRENT THYROID CANCER AFTER RADICAL SURGERY | 2024 |
|
RU2822578C1 |
| METHOD FOR DIAGNOSING MALIGNANT NEOPLASMS OF THYROID GLAND | 2023 |
|
RU2820815C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF THYROID NEOPLASMS | 2019 |
|
RU2705110C1 |
| METHOD FOR DETERMINING THERAPEUTIC APPROACH TO DIFFERENTIATED THYROID CARCINOMA COMBINED WITH HASHIMOTO'S THYROIDITIS WITH JUNCTION | 2013 |
|
RU2522388C1 |
| METHOD FOR PREOPERATIVE DETERMINATION OF VOLUME OF SURGICAL TREATMENT OF HIGH-DIFFERENTIATED THYROID CANCER | 2018 |
|
RU2709140C1 |
| METHOD FOR SURGICAL TREATMENT OF THYROID CANCER IN THYROTOXICOSIS | 2020 |
|
RU2751971C1 |
| METHOD OF DETERMINING RISK OF DEVELOPING PAPILLARY THYROID CANCER | 2023 |
|
RU2807880C1 |
| METHOD FOR PREOPERATIVE DETERMINATION OF EXTENT OF SURGERY FOR HIGH-DIFFERENTIATED THYROID CARCINOMA | 2014 |
|
RU2548783C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF NODULAR FORMATIONS OF THE HUMAN THYROID GLAND | 2021 |
|
RU2757347C1 |
| METHOD FOR COMPLEX PREOPERATIVE DIFFERENTIAL DIAGNOSIS OF BENIGN AND MALIGNANT NODULES OF THE THYROID GLAND | 2022 |
|
RU2805941C1 |
